202 related articles for article (PubMed ID: 12015763)
1. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity.
Yang DH; Smith ER; Cohen C; Wu H; Patriotis C; Godwin AK; Hamilton TC; Xu XX
Cancer; 2002 May; 94(9):2380-92. PubMed ID: 12015763
[TBL] [Abstract][Full Text] [Related]
2. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
[TBL] [Abstract][Full Text] [Related]
3. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
[TBL] [Abstract][Full Text] [Related]
4. Disabled-2 inactivation is an early step in ovarian tumorigenicity.
Fazili Z; Sun W; Mittelstaedt S; Cohen C; Xu XX
Oncogene; 1999 May; 18(20):3104-13. PubMed ID: 10340382
[TBL] [Abstract][Full Text] [Related]
5. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.
Sheng Z; Sun W; Smith E; Cohen C; Sheng Z; Xu XX
Oncogene; 2000 Oct; 19(42):4847-54. PubMed ID: 11039902
[TBL] [Abstract][Full Text] [Related]
6. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes.
Auersperg N; Maines-Bandiera SL; Dyck HG; Kruk PA
Lab Invest; 1994 Oct; 71(4):510-8. PubMed ID: 7967506
[TBL] [Abstract][Full Text] [Related]
8. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.
Capo-chichi CD; Roland IH; Vanderveer L; Bao R; Yamagata T; Hirai H; Cohen C; Hamilton TC; Godwin AK; Xu XX
Cancer Res; 2003 Aug; 63(16):4967-77. PubMed ID: 12941822
[TBL] [Abstract][Full Text] [Related]
9. Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2).
Sheng Z; He J; Tuppen JA; Sun W; Fazili Z; Smith ER; Dong FB; Xu XX
Genomics; 2000 Dec; 70(3):381-6. PubMed ID: 11161789
[TBL] [Abstract][Full Text] [Related]
10. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer.
Bagadi SA; Prasad CP; Srivastava A; Prashad R; Gupta SD; Ralhan R
Breast Cancer Res Treat; 2007 Sep; 104(3):277-86. PubMed ID: 17115114
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
[TBL] [Abstract][Full Text] [Related]
13. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
14. [Distribution of laminin, type IV collagen and fibronectin in normal, dysplastic and neoplastic laryngeal tissue].
Nicolai P; Cappiello J; Peretti G; Antonelli AR; Parolini S; Rosa D; Favret M; Maroccolo D; Molinari Tosatti MP
Acta Otorhinolaryngol Ital; 1990; 10(2):139-49. PubMed ID: 2260438
[TBL] [Abstract][Full Text] [Related]
15. Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.
Cai KQ; Yang WL; Capo-Chichi CD; Vanderveer L; Wu H; Godwin AK; Xu XX
Mol Carcinog; 2007 Feb; 46(2):130-43. PubMed ID: 17131304
[TBL] [Abstract][Full Text] [Related]
16. Prognostic aspects of the loss of epithelial basement membrane components in preinvasive and invasive laryngeal carcinomas.
Hagedorn HG; Tübel J; Wiest I; Schleicher ED; Nerlich AG
Anticancer Res; 1998; 18(1A):201-7. PubMed ID: 9568078
[TBL] [Abstract][Full Text] [Related]
17. Localization of the alpha 3 beta 1 integrin in some common epithelial tumors of the ovary and in normal equivalents.
Bartolazzi A; Kaczmarek J; Nicoló G; Risso AM; Tarone G; Rossino P; Defilippi P; Castellani P
Anticancer Res; 1993; 13(1):1-11. PubMed ID: 8476198
[TBL] [Abstract][Full Text] [Related]
18. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
Piek JM; van Diest PJ; Zweemer RP; Jansen JW; Poort-Keesom RJ; Menko FH; Gille JJ; Jongsma AP; Pals G; Kenemans P; Verheijen RH
J Pathol; 2001 Nov; 195(4):451-6. PubMed ID: 11745677
[TBL] [Abstract][Full Text] [Related]
19. Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin.
Skubitz AP; Bast RC; Wayner EA; Letourneau PC; Wilke MS
Am J Pathol; 1996 May; 148(5):1445-61. PubMed ID: 8623916
[TBL] [Abstract][Full Text] [Related]
20. [Basement membranes of epithelial tumors of the ovary. Histochemical and immunohistochemical study using antibodies to collagen IV, III, I and to laminin].
Frappart L; Agard C; Lin HC; Grimaud JA; Palayer C; Rochet Y; Brémond A
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(2):117-23. PubMed ID: 6736588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
